The evolution of natural history of primary sclerosing cholangitis

Will R. Takakura, James H. Tabibian, Christopher Bowlus

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

Purpose of review Primary sclerosing cholangitis (PSC) is a rare, idiopathic biliary disease often with an insidious onset, variable disease course, and premature death related to benign and malignant PSC-related sequelae. This review aims to discuss the epidemiology, clinical variants, and natural history of PSC, incorporating data from recent population-based studies. Recent findings PSC naturally leads to cirrhosis, cholangiocarcinoma, other hepatobiliary malignancies, dominant strictures, hepatic osteodystrophy, and bacterial cholangitis. The incidence of PSC appears to be increasing, the reasons for which are unclear. The time from diagnosis to liver transplant appears to be longer in more recent studies compared with earlier studies, suggesting a better overall prognosis than previously believed. In addition, with an increasing number of patients undergoing liver transplantation for PSC, the frequency of death because of liver failure has decreased, whereas cancer-related deaths have increased among patients with PSC. Summary PSC is a heterogeneous disease with a variety of clinical outcomes, both fatal and nonfatal. The progression of liver fibrosis in an individual patient is difficult to predict and may vary from a relatively benign, nonprogressive form to a rapidly progressive form with the need for liver transplantation.

Original languageEnglish (US)
Pages (from-to)71-77
Number of pages7
JournalCurrent Opinion in Gastroenterology
Volume33
Issue number2
DOIs
StatePublished - Mar 1 2017

Fingerprint

Sclerosing Cholangitis
Liver Transplantation
Premature Mortality
Cholangitis
Fatal Outcome
Cholangiocarcinoma
Liver
Liver Failure
Liver Cirrhosis
Neoplasms
Pathologic Constriction
Epidemiology
Fibrosis
Transplants
Incidence

Keywords

  • Biliary Tract Disease
  • Epidemiology
  • Outcomes
  • Prognosis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The evolution of natural history of primary sclerosing cholangitis. / Takakura, Will R.; Tabibian, James H.; Bowlus, Christopher.

In: Current Opinion in Gastroenterology, Vol. 33, No. 2, 01.03.2017, p. 71-77.

Research output: Contribution to journalReview article

Takakura, Will R. ; Tabibian, James H. ; Bowlus, Christopher. / The evolution of natural history of primary sclerosing cholangitis. In: Current Opinion in Gastroenterology. 2017 ; Vol. 33, No. 2. pp. 71-77.
@article{553f9c278fd647fab6b257ff2b6fbd1a,
title = "The evolution of natural history of primary sclerosing cholangitis",
abstract = "Purpose of review Primary sclerosing cholangitis (PSC) is a rare, idiopathic biliary disease often with an insidious onset, variable disease course, and premature death related to benign and malignant PSC-related sequelae. This review aims to discuss the epidemiology, clinical variants, and natural history of PSC, incorporating data from recent population-based studies. Recent findings PSC naturally leads to cirrhosis, cholangiocarcinoma, other hepatobiliary malignancies, dominant strictures, hepatic osteodystrophy, and bacterial cholangitis. The incidence of PSC appears to be increasing, the reasons for which are unclear. The time from diagnosis to liver transplant appears to be longer in more recent studies compared with earlier studies, suggesting a better overall prognosis than previously believed. In addition, with an increasing number of patients undergoing liver transplantation for PSC, the frequency of death because of liver failure has decreased, whereas cancer-related deaths have increased among patients with PSC. Summary PSC is a heterogeneous disease with a variety of clinical outcomes, both fatal and nonfatal. The progression of liver fibrosis in an individual patient is difficult to predict and may vary from a relatively benign, nonprogressive form to a rapidly progressive form with the need for liver transplantation.",
keywords = "Biliary Tract Disease, Epidemiology, Outcomes, Prognosis",
author = "Takakura, {Will R.} and Tabibian, {James H.} and Christopher Bowlus",
year = "2017",
month = "3",
day = "1",
doi = "10.1097/MOG.0000000000000341",
language = "English (US)",
volume = "33",
pages = "71--77",
journal = "Current Opinion in Gastroenterology",
issn = "0267-1379",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - The evolution of natural history of primary sclerosing cholangitis

AU - Takakura, Will R.

AU - Tabibian, James H.

AU - Bowlus, Christopher

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Purpose of review Primary sclerosing cholangitis (PSC) is a rare, idiopathic biliary disease often with an insidious onset, variable disease course, and premature death related to benign and malignant PSC-related sequelae. This review aims to discuss the epidemiology, clinical variants, and natural history of PSC, incorporating data from recent population-based studies. Recent findings PSC naturally leads to cirrhosis, cholangiocarcinoma, other hepatobiliary malignancies, dominant strictures, hepatic osteodystrophy, and bacterial cholangitis. The incidence of PSC appears to be increasing, the reasons for which are unclear. The time from diagnosis to liver transplant appears to be longer in more recent studies compared with earlier studies, suggesting a better overall prognosis than previously believed. In addition, with an increasing number of patients undergoing liver transplantation for PSC, the frequency of death because of liver failure has decreased, whereas cancer-related deaths have increased among patients with PSC. Summary PSC is a heterogeneous disease with a variety of clinical outcomes, both fatal and nonfatal. The progression of liver fibrosis in an individual patient is difficult to predict and may vary from a relatively benign, nonprogressive form to a rapidly progressive form with the need for liver transplantation.

AB - Purpose of review Primary sclerosing cholangitis (PSC) is a rare, idiopathic biliary disease often with an insidious onset, variable disease course, and premature death related to benign and malignant PSC-related sequelae. This review aims to discuss the epidemiology, clinical variants, and natural history of PSC, incorporating data from recent population-based studies. Recent findings PSC naturally leads to cirrhosis, cholangiocarcinoma, other hepatobiliary malignancies, dominant strictures, hepatic osteodystrophy, and bacterial cholangitis. The incidence of PSC appears to be increasing, the reasons for which are unclear. The time from diagnosis to liver transplant appears to be longer in more recent studies compared with earlier studies, suggesting a better overall prognosis than previously believed. In addition, with an increasing number of patients undergoing liver transplantation for PSC, the frequency of death because of liver failure has decreased, whereas cancer-related deaths have increased among patients with PSC. Summary PSC is a heterogeneous disease with a variety of clinical outcomes, both fatal and nonfatal. The progression of liver fibrosis in an individual patient is difficult to predict and may vary from a relatively benign, nonprogressive form to a rapidly progressive form with the need for liver transplantation.

KW - Biliary Tract Disease

KW - Epidemiology

KW - Outcomes

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85027943670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85027943670&partnerID=8YFLogxK

U2 - 10.1097/MOG.0000000000000341

DO - 10.1097/MOG.0000000000000341

M3 - Review article

C2 - 28030370

AN - SCOPUS:85027943670

VL - 33

SP - 71

EP - 77

JO - Current Opinion in Gastroenterology

JF - Current Opinion in Gastroenterology

SN - 0267-1379

IS - 2

ER -